Related Experiment Video
Updated: Jun 8, 2026
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
[Will vaccines appear on the scene of oncology in the near future?]
1Ustav hematologie a krevní transfuze Praha. vladimir.vonka@uhkt.cz
Abstract:
In parallel with the increasing knowledge of the role played by the immune system in the control oftumourgrowth, the efforts to develop anti-cancer vaccines intensify. In the present time two highly efficient prophylactic vaccines against the virus-induced cancers are in use, but a rapid progress in the development of anti-cancer therapeutic vaccines can also be seen. It is conditioned by an increasing understanding of the biology of the tumor cells and the rapid progress in the field of immunology. Nevertheless, these developments are associated with a number of difficulties, among which the immunosuppressive activities of the tumor cells and the tumor microenvironment are the most important. On the example of chronic myeloid leukemia the author proposes a strategy for the development ofa therapeutic cancer vaccine.
Insights
Cancer vaccine development is advancing rapidly, driven by immunology and tumor biology insights. Challenges like tumor immunosuppression are being addressed, with a proposed strategy for chronic myeloid leukemia therapeutic cancer vaccines.
Area of Science:
- Immunology
- Oncology
- Vaccinology
Context:
- Growing understanding of the immune system's role in controlling tumor growth.
- Development of prophylactic vaccines against virus-induced cancers.
- Advancements in tumor cell biology and immunology fuel therapeutic vaccine research.
Purpose:
- To discuss the progress and challenges in developing therapeutic anti-cancer vaccines.
- To propose a strategy for developing a therapeutic cancer vaccine using chronic myeloid leukemia as an example.
Summary:
- Therapeutic cancer vaccine development faces hurdles, notably immunosuppressive tumor cells and microenvironments.
- The paper outlines a strategic approach to overcome these challenges.
- Focuses on chronic myeloid leukemia as a model for vaccine development.
Impact:
- Aims to guide the development of effective therapeutic cancer vaccines.
- Addresses critical barriers in current anti-cancer vaccine research.
- Offers a potential pathway for treating established cancers.
Related Concept Videos
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:27Tumor Immunotherapy
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...